Prediction of Alzheimer's dementia

被引:1
|
作者
Jessen, F. [1 ]
Dodel, R. [2 ]
机构
[1] Univ Klinikum Bonn, Klin & Poliklin Psychiat & Psychotherapie, Klin Behandlungs & Forschungszentrum Neurodegener, DZNE, Bonn, Germany
[2] Univ Marburg, Klin & Poliklin Neurol, D-35043 Marburg, Germany
来源
NERVENARZT | 2014年 / 85卷 / 10期
关键词
Alzheimer's dementia; Prediction; Mild cognitive impairment; Biomarkers; Prevention; MILD COGNITIVE IMPAIRMENT; DISEASE; MCI; BIOMARKERS;
D O I
10.1007/s00115-014-4064-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The prediction of Alzheimer's dementia is relevant for the development and design of prevention trials but also for individual counselling of patients. There are two key characteristics which determine the level of prediction that can be achieved. Firstly, the prevalence of Alzheimer's dementia in the respective setting is important. In low prevalence settings, such as primary care populations, it is probably impossible to achieve positive predictive values above 50 %. In high prevalence settings, such as memory clinics, the positive predictive value of Alzheimer's dementia can be much higher. The second major characteristic is the level of cognitive impairment of an individual. The predictive power for Alzheimer's dementia increases from the cognitively healthy status to the status of progressive mild cognitive impairment. Prediction can further be increased by the use of cerebral spinal fluid and brain imaging biomarkers of Alzheimer's disease. The combination of different biomarkers may increase prediction even further. The present article reviews studies and outlines the principles of prediction of Alzheimer's dementia.
引用
收藏
页码:1233 / 1237
页数:5
相关论文
共 50 条
  • [41] Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia Subjects
    Lewczuk, Piotr
    Kornhuber, Johannes
    Toledo, Jon B.
    Trojanowski, John Q.
    Knapik-Czajka, Malgorzata
    Peters, Oliver
    Wiltfang, Jens
    Shaw, Leslie M.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 48 (02) : 433 - 441
  • [42] Frontiers in Alzheimer's and Dementia Research
    Kusakabe, Ken-ichi
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2024, 72 (07) : 600 - 601
  • [43] Estrogen therapy and Alzheimer's dementia
    Craig, Michael C.
    Murphy, D. G. M.
    WOMEN'S HEALTH AND DISEASE, 2010, 1205 : 245 - 253
  • [44] Dementia Experimental Alzheimer's drug
    Wilson, Care
    NEW SCIENTIST, 2019, 243 (3240) : 14 - 14
  • [45] Neurosonological markers of Alzheimer's dementia
    Urbanova, B.
    Magerova, H.
    Horinek, D.
    Tomek, A.
    Hort, J.
    CEREBROVASCULAR DISEASES, 2013, 35 : 512 - 512
  • [46] Pathogenesis of Alzheimer's disease and dementia
    Bugiani, O
    REVUE NEUROLOGIQUE, 1999, 155 : 4S28 - 4S32
  • [47] Astroglia in dementia and Alzheimer's disease
    J J Rodríguez
    M Olabarria
    A Chvatal
    A Verkhratsky
    Cell Death & Differentiation, 2009, 16 : 378 - 385
  • [48] OXIDATIVE STRESS IN ALZHEIMER'S DEMENTIA
    Iova, Andrada
    Micle, Otilia
    Vicas, Laura
    Micle, Liana
    Iova, Sorin
    Muresan, Mariana
    Ionita, Corina Ana
    FARMACIA, 2014, 62 (03) : 538 - 546
  • [49] Cognitive training in Alzheimer's dementia
    Werheid, K.
    Thoene-Otto, A.
    NERVENARZT, 2006, 77 (05): : 549 - +
  • [50] Patients with dementia and Alzheimer's in Hungary
    Gresz, Miklos
    Borbas, Fanni Farkas
    INTERNATIONAL JOURNAL OF INTEGRATED CARE, 2017, 17